Frequencies for first 10,000 rows of indi_pt variable in indi2013q4 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- Abdominal discomfort | 5 0.05 0.05 Abdominal pain | 28 0.28 0.33 Abdominal pain upper | 6 0.06 0.39 Accidental exposure to product | 4 0.04 0.43 Accidental exposure to product by child | 2 0.02 0.45 Acidosis | 1 0.01 0.46 Acne | 322 3.22 3.68 Acne cystic | 16 0.16 3.84 Acromegaly | 7 0.07 3.91 Acute coronary syndrome | 5 0.05 3.96 Acute leukaemia | 1 0.01 3.97 Acute lymphocytic leukaemia | 15 0.15 4.12 Acute myeloid leukaemia | 16 0.16 4.28 Acute sinusitis | 1 0.01 4.29 Addison's disease | 5 0.05 4.34 Adenocarcinoma | 3 0.03 4.37 Adjuvant therapy | 1 0.01 4.38 Adrenal disorder | 1 0.01 4.39 Adrenocorticotropic hormone deficiency | 1 0.01 4.40 Adverse drug reaction | 2 0.02 4.42 Affective disorder | 7 0.07 4.49 Age-related macular degeneration | 7 0.07 4.56 Agitated depression | 1 0.01 4.57 Agitation | 21 0.21 4.78 Alcohol use | 1 0.01 4.79 Allergy prophylaxis | 1 0.01 4.80 Alopecia | 5 0.05 4.85 Anaemia | 21 0.21 5.06 Anaesthesia | 1 0.01 5.07 Analgesic therapy | 25 0.25 5.32 Anaphylactic reaction | 2 0.02 5.34 Anaplastic large cell lymphoma T- and.. | 1 0.01 5.35 Anger | 4 0.04 5.39 Angina pectoris | 10 0.10 5.49 Angiogram | 1 0.01 5.50 Ankylosing spondylitis | 8 0.08 5.58 Antacid therapy | 3 0.03 5.61 Antasthmatic drug level | 1 0.01 5.62 Anti-infective therapy | 1 0.01 5.63 Antiallergic therapy | 3 0.03 5.66 Antibiotic prophylaxis | 5 0.05 5.71 Antibiotic therapy | 6 0.06 5.77 Anticoagulant therapy | 23 0.23 6.00 Antidepressant therapy | 3 0.03 6.03 Antiemetic supportive care | 2 0.02 6.05 Antifungal prophylaxis | 5 0.05 6.10 Antifungal treatment | 1 0.01 6.11 Antiinflammatory therapy | 3 0.03 6.14 Antiplatelet therapy | 4 0.04 6.18 Antiretroviral therapy | 4 0.04 6.22 Antithrombin III | 1 0.01 6.23 Antiviral prophylaxis | 2 0.02 6.25 Anxiety | 133 1.33 7.58 Anxiety disorder | 8 0.08 7.66 Aortic valve incompetence | 1 0.01 7.67 Aphthous stomatitis | 1 0.01 7.68 Aplasia pure red cell | 3 0.03 7.71 Aplastic anaemia | 9 0.09 7.80 Appetite disorder | 1 0.01 7.81 Arnold-Chiari malformation | 1 0.01 7.82 Arrhythmia | 8 0.08 7.90 Arterial disorder | 1 0.01 7.91 Arteriogram renal | 1 0.01 7.92 Arthralgia | 22 0.22 8.14 Arthritis | 31 0.31 8.45 Arthritis bacterial | 5 0.05 8.50 Arthropathy | 5 0.05 8.55 Asbestosis | 2 0.02 8.57 Ascites | 3 0.03 8.60 Aspergillus infection | 1 0.01 8.61 Asthma | 105 1.05 9.66 Asthma exercise induced | 1 0.01 9.67 Asthmatic crisis | 1 0.01 9.68 Astrocytoma | 2 0.02 9.70 Astrocytoma malignant | 1 0.01 9.71 Astrocytoma, low grade | 1 0.01 9.72 Atherosclerosis prophylaxis | 2 0.02 9.74 Atrial fibrillation | 61 0.61 10.35 Atrial flutter | 5 0.05 10.40 Atrioventricular block | 2 0.02 10.42 Attention deficit/hyperactivity disor.. | 7 0.07 10.49 Autoimmune hepatitis | 1 0.01 10.50 Autologous bone marrow transplantatio.. | 1 0.01 10.51 B-cell lymphoma | 7 0.07 10.58 Back disorder | 5 0.05 10.63 Back pain | 72 0.72 11.35 Bacterial infection | 2 0.02 11.37 Balance disorder | 1 0.01 11.38 Barrett's oesophagus | 9 0.09 11.47 Benign prostatic hyperplasia | 8 0.08 11.55 Biliary colic | 2 0.02 11.57 Bipolar I disorder | 42 0.42 11.99 Bipolar II disorder | 4 0.04 12.03 Bipolar disorder | 112 1.12 13.15 Bladder cancer | 10 0.10 13.25 Bladder disorder | 7 0.07 13.32 Bladder mass | 1 0.01 13.33 Bladder obstruction | 3 0.03 13.36 Blast crisis in myelogenous leukaemia | 2 0.02 13.38 Blood calcium | 1 0.01 13.39 Blood cholesterol | 11 0.11 13.50 Blood cholesterol abnormal | 29 0.29 13.79 Blood cholesterol increased | 54 0.54 14.33 Blood creatinine increased | 2 0.02 14.35 Blood disorder | 4 0.04 14.39 Blood follicle stimulating hormone de.. | 2 0.02 14.41 Blood glucose abnormal | 4 0.04 14.45 Blood glucose increased | 4 0.04 14.49 Blood growth hormone decreased | 1 0.01 14.50 Blood immunoglobulin E increased | 1 0.01 14.51 Blood luteinising hormone decreased | 2 0.02 14.53 Blood phosphorus increased | 2 0.02 14.55 Blood potassium | 1 0.01 14.56 Blood potassium decreased | 2 0.02 14.58 Blood pressure | 23 0.23 14.81 Blood pressure abnormal | 49 0.49 15.30 Blood pressure increased | 4 0.04 15.34 Blood pressure management | 4 0.04 15.38 Blood thyroid stimulating hormone dec.. | 1 0.01 15.39 Blood triglycerides abnormal | 1 0.01 15.40 Blood triglycerides increased | 1 0.01 15.41 Blood uric acid abnormal | 1 0.01 15.42 Bone density abnormal | 1 0.01 15.43 Bone disorder | 4 0.04 15.47 Bone lesion | 1 0.01 15.48 Bone marrow conditioning regimen | 3 0.03 15.51 Bone marrow failure | 2 0.02 15.53 Bone marrow transplant | 2 0.02 15.55 Bone pain | 1 0.01 15.56 Borderline personality disorder | 2 0.02 15.58 Brain neoplasm | 3 0.03 15.61 Brain neoplasm benign | 2 0.02 15.63 Brain oedema | 1 0.01 15.64 Brain stem infarction | 2 0.02 15.66 Brain stem stroke | 1 0.01 15.67 Breakthrough pain | 8 0.08 15.75 Breast cancer | 53 0.53 16.28 Breast cancer female | 5 0.05 16.33 Breast cancer metastatic | 17 0.17 16.50 Breast disorder | 1 0.01 16.51 Bronchial carcinoma | 2 0.02 16.53 Bronchial irritation | 1 0.01 16.54 Bronchiectasis | 2 0.02 16.56 Bronchitis | 8 0.08 16.64 Bronchitis chronic | 1 0.01 16.65 Bronchopneumonia | 1 0.01 16.66 Bronchopulmonary dysplasia | 1 0.01 16.67 Burning sensation | 2 0.02 16.69 Bursitis | 2 0.02 16.71 C-reactive protein increased | 3 0.03 16.74 Calcium deficiency | 1 0.01 16.75 Calculus ureteric | 1 0.01 16.76 Cancer pain | 3 0.03 16.79 Candida infection | 3 0.03 16.82 Carcinoid tumour | 1 0.01 16.83 Carcinoid tumour of the gastrointesti.. | 1 0.01 16.84 Cardiac disorder | 61 0.61 17.45 Cardiac failure | 17 0.17 17.62 Cardiac failure chronic | 1 0.01 17.63 Cardiac failure congestive | 3 0.03 17.66 Cardiomyopathy | 2 0.02 17.68 Cardiovascular event prophylaxis | 15 0.15 17.83 Carotid artery occlusion | 1 0.01 17.84 Castleman's disease | 4 0.04 17.88 Cataplexy | 6 0.06 17.94 Catheterisation cardiac | 1 0.01 17.95 Cellulitis | 4 0.04 17.99 Cerebral infarction | 3 0.03 18.02 Cerebral palsy | 2 0.02 18.04 Cerebrovascular accident | 1 0.01 18.05 Cerebrovascular accident prophylaxis | 8 0.08 18.13 Chemotherapy | 5 0.05 18.18 Chest pain | 10 0.10 18.28 Cholecystitis | 2 0.02 18.30 Cholelithiasis | 2 0.02 18.32 Choroidal neovascularisation | 1 0.01 18.33 Chronic fatigue syndrome | 3 0.03 18.36 Chronic graft versus host disease | 1 0.01 18.37 Chronic granulomatous disease | 2 0.02 18.39 Chronic hepatitis B | 5 0.05 18.44 Chronic hepatitis C | 20 0.20 18.64 Chronic lymphocytic leukaemia | 14 0.14 18.78 Chronic myeloid leukaemia | 55 0.55 19.33 Chronic obstructive pulmonary disease | 71 0.71 20.04 Chronic sinusitis | 1 0.01 20.05 Clinically isolated syndrome | 1 0.01 20.06 Clostridium difficile colitis | 1 0.01 20.07 Coagulopathy | 1 0.01 20.08 Cold type haemolytic anaemia | 1 0.01 20.09 Colectomy | 1 0.01 20.10 Colitis | 1 0.01 20.11 Colitis ulcerative | 42 0.42 20.53 Colon cancer | 8 0.08 20.61 Colon cancer metastatic | 4 0.04 20.65 Colonoscopy | 69 0.69 21.34 Colony stimulating factor therapy | 2 0.02 21.36 Colorectal cancer | 10 0.10 21.46 Colorectal cancer metastatic | 12 0.12 21.58 Complex regional pain syndrome | 4 0.04 21.62 Compression fracture | 1 0.01 21.63 Confusional state | 2 0.02 21.65 Connective tissue disorder | 3 0.03 21.68 Constipation | 32 0.32 22.00 Constipation prophylaxis | 3 0.03 22.03 Contraception | 302 3.02 25.05 Convulsion | 25 0.25 25.30 Convulsion prophylaxis | 1 0.01 25.31 Cor pulmonale | 2 0.02 25.33 Coronary artery bypass | 3 0.03 25.36 Coronary artery disease | 15 0.15 25.51 Coronary artery occlusion | 1 0.01 25.52 Coronary artery stenosis | 6 0.06 25.58 Costochondritis | 1 0.01 25.59 Cough | 5 0.05 25.64 Crohn's disease | 90 0.90 26.54 Cystic fibrosis | 5 0.05 26.59 Cystitis | 4 0.04 26.63 Cystitis haemorrhagic | 2 0.02 26.65 Cystitis interstitial | 3 0.03 26.68 Decreased appetite | 5 0.05 26.73 Deep vein thrombosis | 9 0.09 26.82 Dehydration | 4 0.04 26.86 Dementia | 1 0.01 26.87 Dementia Alzheimer's type | 2 0.02 26.89 Depressed mood | 1 0.01 26.90 Depression | 200 2.00 28.90 Dermal cyst | 1 0.01 28.91 Dermatitis allergic | 1 0.01 28.92 Dermatomyositis | 2 0.02 28.94 DiGeorge's syndrome | 1 0.01 28.95 Diabetes mellitus | 538 5.38 34.33 Diabetes mellitus management | 1 0.01 34.34 Diabetes prophylaxis | 1 0.01 34.35 Diabetic foot | 2 0.02 34.37 Diabetic neuropathy | 5 0.05 34.42 Diagnostic procedure | 4 0.04 34.46 Diarrhoea | 13 0.13 34.59 Diffuse large B-cell lymphoma | 29 0.29 34.88 Discomfort | 2 0.02 34.90 Disseminated intravascular coagulation | 2 0.02 34.92 Diuretic therapy | 7 0.07 34.99 Diverticulitis | 2 0.02 35.01 Dizziness | 4 0.04 35.05 Drug abuse | 5 0.05 35.10 Drug dependence | 3 0.03 35.13 Drug level | 1 0.01 35.14 Drug therapy | 3 0.03 35.17 Dry eye | 3 0.03 35.20 Dry skin | 1 0.01 35.21 Dupuytren's contracture | 1 0.01 35.22 Dysfunctional uterine bleeding | 1 0.01 35.23 Dyslipidaemia | 24 0.24 35.47 Dysmenorrhoea | 16 0.16 35.63 Dyspepsia | 22 0.22 35.85 Dysphagia | 1 0.01 35.86 Dyspnoea | 7 0.07 35.93 Dysuria | 3 0.03 35.96 Ear infection | 3 0.03 35.99 Eczema | 4 0.04 36.03 Electrolyte imbalance | 1 0.01 36.04 Embolism | 6 0.06 36.10 Embolism arterial | 2 0.02 36.12 Emergency care | 1 0.01 36.13 Emphysema | 9 0.09 36.22 Encephalopathy | 3 0.03 36.25 Endometriosis | 3 0.03 36.28 Endoscopy upper gastrointestinal tract | 1 0.01 36.29 Epidural analgesia | 2 0.02 36.31 Epigastric discomfort | 2 0.02 36.33 Epilepsy | 28 0.28 36.61 Erectile dysfunction | 3 0.03 36.64 Essential hypertension | 6 0.06 36.70 Essential thrombocythaemia | 3 0.03 36.73 Ex-tobacco user | 1 0.01 36.74 Exposure during pregnancy | 3 0.03 36.77 Extrapyramidal disorder | 2 0.02 36.79 Extrasystoles | 1 0.01 36.80 Eye disorder | 1 0.01 36.81 Fatigue | 3 0.03 36.84 Fear | 3 0.03 36.87 Fibroma | 1 0.01 36.88 Fibromyalgia | 25 0.25 37.13 Fibrous dysplasia of bone | 1 0.01 37.14 Fistula | 1 0.01 37.15 Flatulence | 1 0.01 37.16 Fluid replacement | 3 0.03 37.19 Fluid retention | 5 0.05 37.24 Foetal exposure during pregnancy | 29 0.29 37.53 Foreign body sensation in eyes | 1 0.01 37.54 Functional gastrointestinal disorder | 1 0.01 37.55 Fungal infection | 7 0.07 37.62 Gait disturbance | 1 0.01 37.63 Gallbladder disorder | 1 0.01 37.64 Gastric cancer | 9 0.09 37.73 Gastric disorder | 15 0.15 37.88 Gastric mucosal lesion | 1 0.01 37.89 Gastric pH decreased | 1 0.01 37.90 Gastric ulcer | 3 0.03 37.93 Gastritis | 19 0.19 38.12 Gastritis erosive | 1 0.01 38.13 Gastritis prophylaxis | 4 0.04 38.17 Gastroenteritis | 3 0.03 38.20 Gastroenteritis viral | 2 0.02 38.22 Gastrointestinal disorder | 2 0.02 38.24 Gastrointestinal disorder therapy | 1 0.01 38.25 Gastrointestinal neoplasm | 1 0.01 38.26 Gastrointestinal pain | 1 0.01 38.27 Gastrointestinal stromal tumour | 8 0.08 38.35 Gastrointestinal ulcer | 1 0.01 38.36 Gastrooesophageal reflux disease | 193 1.93 40.29 General physical condition | 1 0.01 40.30 Genital herpes | 1 0.01 40.31 Germ cell cancer | 7 0.07 40.38 Gestational diabetes | 1 0.01 40.39 Gingivitis | 2 0.02 40.41 Glaucoma | 11 0.11 40.52 Glioblastoma | 14 0.14 40.66 Glioblastoma multiforme | 7 0.07 40.73 Glucose tolerance impaired | 1 0.01 40.74 Gout | 6 0.06 40.80 Graft versus host disease | 5 0.05 40.85 Grand mal convulsion | 1 0.01 40.86 Granulomatosis with polyangiitis | 1 0.01 40.87 Gravitational oedema | 1 0.01 40.88 Growth hormone deficiency | 2 0.02 40.90 Guttate psoriasis | 1 0.01 40.91 HER-2 positive breast cancer | 20 0.20 41.11 HIV infection | 80 0.80 41.91 Haemolysis | 1 0.01 41.92 Haemolytic anaemia | 1 0.01 41.93 Haemolytic uraemic syndrome | 4 0.04 41.97 Haemorrhage | 2 0.02 41.99 Haemorrhage prophylaxis | 1 0.01 42.00 Haemorrhoids | 3 0.03 42.03 Haemosiderosis | 1 0.01 42.04 Head and neck cancer | 5 0.05 42.09 Head discomfort | 1 0.01 42.10 Headache | 27 0.27 42.37 Heart rate | 4 0.04 42.41 Heart rate abnormal | 1 0.01 42.42 Heart rate decreased | 1 0.01 42.43 Heart rate increased | 1 0.01 42.44 Heart transplant | 5 0.05 42.49 Helicobacter infection | 5 0.05 42.54 Hemiparesis | 1 0.01 42.55 Hepatic cancer | 3 0.03 42.58 Hepatic cirrhosis | 5 0.05 42.63 Hepatic encephalopathy | 2 0.02 42.65 Hepatic failure | 1 0.01 42.66 Hepatic function abnormal | 1 0.01 42.67 Hepatic steatosis | 2 0.02 42.69 Hepatitis B | 4 0.04 42.73 Hepatitis C | 26 0.26 42.99 Hepato-lenticular degeneration | 1 0.01 43.00 Hepatocellular carcinoma | 26 0.26 43.26 Hereditary angioedema | 3 0.03 43.29 Hernia | 1 0.01 43.30 Herpes simplex | 2 0.02 43.32 Herpes virus infection | 1 0.01 43.33 Herpes zoster | 1 0.01 43.34 Hiatus hernia | 11 0.11 43.45 Hiccups | 1 0.01 43.46 Hirsutism | 1 0.01 43.47 Hodgkin's disease | 1 0.01 43.48 Hormone level abnormal | 4 0.04 43.52 Hormone replacement therapy | 21 0.21 43.73 Hormone therapy | 2 0.02 43.75 Hot flush | 1 0.01 43.76 Human T-cell lymphotropic virus type .. | 4 0.04 43.80 Hypercholesterolaemia | 19 0.19 43.99 Hyperhidrosis | 1 0.01 44.00 Hyperkalaemia | 1 0.01 44.01 Hyperlipidaemia | 19 0.19 44.20 Hyperparathyroidism secondary | 2 0.02 44.22 Hyperphosphataemia | 2 0.02 44.24 Hypersensitivity | 14 0.14 44.38 Hypertension | 283 2.83 47.21 Hyperthyroidism | 2 0.02 47.23 Hypertonic bladder | 5 0.05 47.28 Hypertriglyceridaemia | 3 0.03 47.31 Hyperuricaemia | 7 0.07 47.38 Hypoaesthesia | 1 0.01 47.39 Hypoalbuminaemia | 1 0.01 47.40 Hypocalcaemia | 2 0.02 47.42 Hypogammaglobulinaemia | 2 0.02 47.44 Hypogonadism | 2 0.02 47.46 Hypokalaemia | 2 0.02 47.48 Hypomagnesaemia | 1 0.01 47.49 Hypopituitarism | 2 0.02 47.51 Hypotension | 4 0.04 47.55 Hypothyroidism | 38 0.38 47.93 Hypotonia | 4 0.04 47.97 Immune system disorder | 1 0.01 47.98 Immune thrombocytopenic purpura | 19 0.19 48.17 Immunisation | 1 0.01 48.18 Immunodeficiency common variable | 1 0.01 48.19 Immunosuppression | 13 0.13 48.32 Impaired gastric emptying | 1 0.01 48.33 Incontinence | 1 0.01 48.34 Increased appetite | 1 0.01 48.35 Induction of anaesthesia | 1 0.01 48.36 Infection | 6 0.06 48.42 Infection prophylaxis | 18 0.18 48.60 Inflammation | 5 0.05 48.65 Inflammatory bowel disease | 6 0.06 48.71 Influenza | 4 0.04 48.75 Influenza like illness | 1 0.01 48.76 Inhalation therapy | 2 0.02 48.78 Insomnia | 39 0.39 49.17 Insulin resistance | 1 0.01 49.18 Interstitial lung disease | 1 0.01 49.19 Intertrigo | 1 0.01 49.20 Intervertebral disc disorder | 1 0.01 49.21 Intervertebral disc protrusion | 2 0.02 49.23 Intestinal fistula | 7 0.07 49.30 Intra-uterine contraceptive device | 1 0.01 49.31 Intraocular pressure increased | 1 0.01 49.32 Iron deficiency | 1 0.01 49.33 Iron deficiency anaemia | 4 0.04 49.37 Iron metabolism disorder | 1 0.01 49.38 Iron overload | 5 0.05 49.43 Irritable bowel syndrome | 9 0.09 49.52 Ischaemic heart disease prophylaxis | 2 0.02 49.54 Joint stiffness | 1 0.01 49.55 Joint swelling | 4 0.04 49.59 Juvenile idiopathic arthritis | 3 0.03 49.62 Kidney transplant rejection | 1 0.01 49.63 Labour induction | 2 0.02 49.65 Labour pain | 1 0.01 49.66 Lacunar infarction | 1 0.01 49.67 Left ventricular dysfunction | 1 0.01 49.68 Lethargy | 1 0.01 49.69 Leukaemia | 2 0.02 49.71 Lipids abnormal | 1 0.01 49.72 Lipids increased | 1 0.01 49.73 Liver disorder | 2 0.02 49.75 Liver transplant | 1 0.01 49.76 Local anaesthesia | 6 0.06 49.82 Local swelling | 1 0.01 49.83 Localised infection | 1 0.01 49.84 Lower respiratory tract infection | 1 0.01 49.85 Lung adenocarcinoma | 1 0.01 49.86 Lung adenocarcinoma metastatic | 2 0.02 49.88 Lung disorder | 11 0.11 49.99 Lung neoplasm malignant | 11 0.11 50.10 Lupus nephritis | 11 0.11 50.21 Lyme disease | 3 0.03 50.24 Lymphadenopathy | 1 0.01 50.25 Lymphangioleiomyomatosis | 1 0.01 50.26 Lymphoedema | 2 0.02 50.28 Lymphoma | 4 0.04 50.32 Macular oedema | 2 0.02 50.34 Maculopathy | 1 0.01 50.35 Major depression | 23 0.23 50.58 Malaise | 4 0.04 50.62 Malaria prophylaxis | 1 0.01 50.63 Malignant atrophic papulosis | 1 0.01 50.64 Malignant lymphoid neoplasm | 6 0.06 50.70 Malignant melanoma | 11 0.11 50.81 Malignant neoplasm of islets of Lange.. | 1 0.01 50.82 Malignant neoplasm progression | 1 0.01 50.83 Malignant urinary tract neoplasm | 1 0.01 50.84 Mania | 4 0.04 50.88 Mantle cell lymphoma | 16 0.16 51.04 Medical diet | 2 0.02 51.06 Medical observation | 1 0.01 51.07 Menopausal depression | 9 0.09 51.16 Menopausal symptoms | 2 0.02 51.18 Menopause | 1 0.01 51.19 Menorrhagia | 14 0.14 51.33 Menstrual cycle management | 25 0.25 51.58 Menstrual disorder | 4 0.04 51.62 Menstruation irregular | 17 0.17 51.79 Mental disorder | 3 0.03 51.82 Metabolic syndrome | 1 0.01 51.83 Metastases to bone | 14 0.14 51.97 Metastases to central nervous system | 1 0.01 51.98 Metastases to liver | 1 0.01 51.99 Metastases to lung | 1 0.01 52.00 Metastasis | 1 0.01 52.01 Metastatic carcinoid tumour | 1 0.01 52.02 Metastatic malignant melanoma | 3 0.03 52.05 Metastatic renal cell carcinoma | 17 0.17 52.22 Micturition urgency | 1 0.01 52.23 Migraine | 53 0.53 52.76 Migraine prophylaxis | 3 0.03 52.79 Mineral supplementation | 9 0.09 52.88 Mitral valve prolapse | 2 0.02 52.90 Mixed connective tissue disease | 3 0.03 52.93 Mood swings | 11 0.11 53.04 Mouth ulceration | 1 0.01 53.05 Movement disorder | 1 0.01 53.06 Mucosal inflammation | 1 0.01 53.07 Multiple allergies | 5 0.05 53.12 Multiple fractures | 1 0.01 53.13 Multiple sclerosis | 505 5.05 58.18 Multiple sclerosis relapse | 1 0.01 58.19 Muscle relaxant therapy | 6 0.06 58.25 Muscle spasms | 26 0.26 58.51 Muscle spasticity | 7 0.07 58.58 Musculoskeletal chest pain | 1 0.01 58.59 Musculoskeletal discomfort | 7 0.07 58.66 Musculoskeletal pain | 2 0.02 58.68 Myalgia | 3 0.03 58.71 Myelodysplastic syndrome | 22 0.22 58.93 Myelofibrosis | 3 0.03 58.96 Myeloid leukaemia | 2 0.02 58.98 Myocardial infarction | 4 0.04 59.02 Myocardial ischaemia | 3 0.03 59.05 Myopia | 1 0.01 59.06 Narcolepsy | 6 0.06 59.12 Nasal congestion | 6 0.06 59.18 Nasopharyngeal cancer | 1 0.01 59.19 Nasopharyngitis | 11 0.11 59.30 Nausea | 49 0.49 59.79 Neck pain | 22 0.22 60.01 Neoplasm malignant | 1 0.01 60.02 Neoplasm prophylaxis | 1 0.01 60.03 Nephrogenic anaemia | 5 0.05 60.08 Nephrolithiasis | 1 0.01 60.09 Nephropathy | 1 0.01 60.10 Nerve injury | 7 0.07 60.17 Nervous system disorder | 3 0.03 60.20 Nervousness | 9 0.09 60.29 Neuralgia | 31 0.31 60.60 Neuroendocrine tumour | 3 0.03 60.63 Neurogenic bladder | 1 0.01 60.64 Neurological infection | 1 0.01 60.65 Neuropathy peripheral | 16 0.16 60.81 Neuropsychiatric lupus | 1 0.01 60.82 Neurotransmitter level altered | 4 0.04 60.86 Niemann-Pick disease | 1 0.01 60.87 Non-Hodgkin's lymphoma | 3 0.03 60.90 Non-small cell lung cancer | 9 0.09 60.99 Non-small cell lung cancer stage IV | 2 0.02 61.01 Nutritional supplementation | 22 0.22 61.23 Obsessive-compulsive disorder | 3 0.03 61.26 Oculogyric crisis | 1 0.01 61.27 Oedema | 4 0.04 61.31 Oedema peripheral | 5 0.05 61.36 Oesophageal carcinoma | 10 0.10 61.46 Off label use | 11 0.11 61.57 Oligomenorrhoea | 2 0.02 61.59 Oral candidiasis | 2 0.02 61.61 Oral contraception | 74 0.74 62.35 Organ transplant | 1 0.01 62.36 Organic erectile dysfunction | 1 0.01 62.37 Osteitis | 4 0.04 62.41 Osteitis deformans | 5 0.05 62.46 Osteoarthritis | 20 0.20 62.66 Osteomyelitis | 3 0.03 62.69 Osteonecrosis of jaw | 1 0.01 62.70 Osteopenia | 13 0.13 62.83 Osteoporosis | 95 0.95 63.78 Osteoporosis postmenopausal | 5 0.05 63.83 Osteoporosis prophylaxis | 9 0.09 63.92 Osteosarcoma | 4 0.04 63.96 Ovarian cancer | 2 0.02 63.98 Ovarian cyst | 8 0.08 64.06 Overweight | 1 0.01 64.07 Oxygen saturation decreased | 1 0.01 64.08 Pain | 266 2.66 66.74 Pain in extremity | 6 0.06 66.80 Pain in jaw | 1 0.01 66.81 Pain management | 4 0.04 66.85 Pain prophylaxis | 2 0.02 66.87 Palpitations | 5 0.05 66.92 Pancreatic carcinoma | 2 0.02 66.94 Pancreatic disorder | 1 0.01 66.95 Pancreatic insufficiency | 1 0.01 66.96 Pancreatic neuroendocrine tumour | 2 0.02 66.98 Pancreatitis | 2 0.02 67.00 Panic attack | 10 0.10 67.10 Panic disorder | 2 0.02 67.12 Paraesthesia | 2 0.02 67.14 Parathyroid disorder | 10 0.10 67.24 Parathyroid gland operation | 1 0.01 67.25 Parathyroidectomy | 3 0.03 67.28 Parenteral nutrition | 6 0.06 67.34 Parkinson's disease | 16 0.16 67.50 Parkinsonism | 1 0.01 67.51 Paroxysmal nocturnal haemoglobinuria | 16 0.16 67.67 Partial seizures | 2 0.02 67.69 Pelvic pain | 2 0.02 67.71 Peptic ulcer | 2 0.02 67.73 Percutaneous coronary intervention | 3 0.03 67.76 Periodic limb movement disorder | 1 0.01 67.77 Peripheral arterial occlusive disease | 2 0.02 67.79 Personality disorder | 9 0.09 67.88 Phaeochromocytoma | 1 0.01 67.89 Pharyngitis | 3 0.03 67.92 Phlebitis | 1 0.01 67.93 Pituitary tumour | 1 0.01 67.94 Pituitary tumour removal | 1 0.01 67.95 Placental disorder | 1 0.01 67.96 Plantar fasciitis | 1 0.01 67.97 Plasma cell leukaemia | 2 0.02 67.99 Plasma cell myeloma | 122 1.22 69.21 Platelet aggregation inhibition | 1 0.01 69.22 Platelet count decreased | 1 0.01 69.23 Platelet disorder | 1 0.01 69.24 Pleurisy | 1 0.01 69.25 Pneumonia | 10 0.10 69.35 Pneumonia aspiration | 1 0.01 69.36 Pneumonia necrotising | 8 0.08 69.44 Pneumonitis | 1 0.01 69.45 Pneumothorax | 2 0.02 69.47 Pollakiuria | 2 0.02 69.49 Polyarthritis | 6 0.06 69.55 Polycystic ovaries | 15 0.15 69.70 Polymyositis | 1 0.01 69.71 Polypoidal choroidal vasculopathy | 1 0.01 69.72 Polyuria | 2 0.02 69.74 Poor quality sleep | 1 0.01 69.75 Portal vein thrombosis | 1 0.01 69.76 Post gastric surgery syndrome | 2 0.02 69.78 Post procedural constipation | 1 0.01 69.79 Post-traumatic stress disorder | 18 0.18 69.97 Postoperative care | 2 0.02 69.99 Postpartum depression | 4 0.04 70.03 Pregnancy | 2 0.02 70.05 Premedication | 41 0.41 70.46 Premenstrual dysphoric disorder | 36 0.36 70.82 Premenstrual pain | 1 0.01 70.83 Premenstrual syndrome | 91 0.91 71.74 Preoperative care | 1 0.01 71.75 Primary hypothyroidism | 1 0.01 71.76 Primary immunodeficiency syndrome | 3 0.03 71.79 Primary progressive multiple sclerosis | 1 0.01 71.80 Probiotic therapy | 1 0.01 71.81 Procedural pain | 4 0.04 71.85 Proctalgia | 3 0.03 71.88 Product used for unknown indication | 1,276 12.76 84.64 Productive cough | 4 0.04 84.68 Prophylaxis | 145 1.45 86.13 Prophylaxis against dehydration | 1 0.01 86.14 Prophylaxis against gastrointestinal .. | 9 0.09 86.23 Prophylaxis against graft versus host.. | 5 0.05 86.28 Prophylaxis against transplant reject.. | 14 0.14 86.42 Prophylaxis of nausea and vomiting | 5 0.05 86.47 Prophylaxis urinary tract infection | 1 0.01 86.48 Prostate cancer | 6 0.06 86.54 Prostatic adenoma | 1 0.01 86.55 Prostatic disorder | 6 0.06 86.61 Prostatomegaly | 1 0.01 86.62 Pruritus | 5 0.05 86.67 Pseudomonas infection | 3 0.03 86.70 Psoriasis | 40 0.40 87.10 Psoriatic arthropathy | 24 0.24 87.34 Psychiatric symptom | 1 0.01 87.35 Psychomotor hyperactivity | 3 0.03 87.38 Psychosomatic disease | 1 0.01 87.39 Psychotic disorder | 16 0.16 87.55 Pulmonary arterial hypertension | 70 0.70 88.25 Pulmonary embolism | 1 0.01 88.26 Pulmonary hypertension | 18 0.18 88.44 Pustular psoriasis | 3 0.03 88.47 Pyrexia | 23 0.23 88.70 Radiation osteitis | 2 0.02 88.72 Rash | 3 0.03 88.75 Rectal cancer | 1 0.01 88.76 Rectal cancer metastatic | 6 0.06 88.82 Red blood cell abnormality | 1 0.01 88.83 Red blood cell count decreased | 1 0.01 88.84 Reflux gastritis | 1 0.01 88.85 Refractory anaemia with an excess of .. | 1 0.01 88.86 Relapsing-remitting multiple sclerosis | 31 0.31 89.17 Renal and pancreas transplant | 2 0.02 89.19 Renal cancer | 5 0.05 89.24 Renal cancer stage IV | 1 0.01 89.25 Renal cell carcinoma | 21 0.21 89.46 Renal cell carcinoma stage IV | 1 0.01 89.47 Renal colic | 2 0.02 89.49 Renal disorder | 1 0.01 89.50 Renal failure | 2 0.02 89.52 Renal failure chronic | 3 0.03 89.55 Renal impairment | 1 0.01 89.56 Renal transplant | 27 0.27 89.83 Respiratory disorder | 5 0.05 89.88 Respiratory therapy | 1 0.01 89.89 Respiratory tract infection | 4 0.04 89.93 Restless legs syndrome | 9 0.09 90.02 Restlessness | 1 0.01 90.03 Rhabdomyosarcoma | 5 0.05 90.08 Rheumatoid arthritis | 264 2.64 92.72 Rhinitis | 1 0.01 92.73 Rhinitis allergic | 7 0.07 92.80 Rosacea | 1 0.01 92.81 Routine health maintenance | 2 0.02 92.83 SAPHO syndrome | 1 0.01 92.84 Sarcoidosis | 4 0.04 92.88 Sarcoma | 1 0.01 92.89 Sarcoma metastatic | 6 0.06 92.95 Scan | 1 0.01 92.96 Scan with contrast | 3 0.03 92.99 Schizoaffective disorder | 11 0.11 93.10 Schizophrenia | 62 0.62 93.72 Schizophrenia, disorganised type | 8 0.08 93.80 Schizophrenia, paranoid type | 17 0.17 93.97 Schizophreniform disorder | 3 0.03 94.00 Sciatica | 1 0.01 94.01 Scleroderma renal crisis | 3 0.03 94.04 Scoliosis | 4 0.04 94.08 Seasonal allergy | 6 0.06 94.14 Sedation | 6 0.06 94.20 Sedative therapy | 1 0.01 94.21 Senile osteoporosis | 2 0.02 94.23 Sepsis | 5 0.05 94.28 Septic shock | 1 0.01 94.29 Short-bowel syndrome | 1 0.01 94.30 Sickle cell anaemia | 1 0.01 94.31 Sigmoidoscopy | 1 0.01 94.32 Sinus congestion | 1 0.01 94.33 Sinus disorder | 2 0.02 94.35 Sinus tachycardia | 4 0.04 94.39 Sinusitis | 15 0.15 94.54 Sjogren's syndrome | 1 0.01 94.55 Skin disorder | 4 0.04 94.59 Skin lesion | 1 0.01 94.60 Skin wrinkling | 1 0.01 94.61 Sleep apnoea syndrome | 4 0.04 94.65 Sleep disorder | 62 0.62 95.27 Sleep disorder therapy | 1 0.01 95.28 Smoking cessation therapy | 11 0.11 95.39 Soft tissue disorder | 1 0.01 95.40 Soft tissue infection | 2 0.02 95.42 Somatoform disorder | 1 0.01 95.43 Somnolence | 4 0.04 95.47 Spinal column stenosis | 3 0.03 95.50 Spinal cord injury | 3 0.03 95.53 Spinal fracture | 3 0.03 95.56 Spinal osteoarthritis | 2 0.02 95.58 Spinal pain | 2 0.02 95.60 Squamous cell carcinoma | 3 0.03 95.63 Squamous cell carcinoma of head and n.. | 3 0.03 95.66 Staphylococcal infection | 10 0.10 95.76 Staphylococcal sepsis | 1 0.01 95.77 Status epilepticus | 3 0.03 95.80 Stent placement | 1 0.01 95.81 Steroid therapy | 2 0.02 95.83 Stevens-Johnson syndrome | 5 0.05 95.88 Still's disease adult onset | 2 0.02 95.90 Stomach lesion excision | 1 0.01 95.91 Stomatitis | 1 0.01 95.92 Streptococcal infection | 1 0.01 95.93 Stress | 3 0.03 95.96 Subacute hepatic failure | 4 0.04 96.00 Suicidal ideation | 1 0.01 96.01 Supplementation therapy | 33 0.33 96.34 Supraventricular tachycardia | 1 0.01 96.35 Surgery | 4 0.04 96.39 Swelling | 3 0.03 96.42 Syncope | 2 0.02 96.44 Synovial sarcoma | 1 0.01 96.45 Systemic lupus erythematosus | 3 0.03 96.48 Systemic mastocytosis | 1 0.01 96.49 T-cell lymphoma | 4 0.04 96.53 Tachyarrhythmia | 2 0.02 96.55 Tachycardia | 10 0.10 96.65 Tendon disorder | 2 0.02 96.67 Tendon pain | 2 0.02 96.69 Tenosynovitis | 4 0.04 96.73 Tension headache | 2 0.02 96.75 Testicular disorder | 1 0.01 96.76 Testicular embryonal carcinoma | 6 0.06 96.82 Thalassaemia beta | 6 0.06 96.88 Therapeutic embolisation | 3 0.03 96.91 Therapeutic emesis | 1 0.01 96.92 Thrombocytopenia | 1 0.01 96.93 Thrombocytopenic purpura | 2 0.02 96.95 Thrombolysis | 1 0.01 96.96 Thrombosis prophylaxis | 16 0.16 97.12 Thrombotic microangiopathy | 1 0.01 97.13 Thyroid cancer | 1 0.01 97.14 Thyroid cancer metastatic | 3 0.03 97.17 Thyroid disorder | 28 0.28 97.45 Thyroid hormone replacement therapy | 1 0.01 97.46 Thyroidectomy | 1 0.01 97.47 Thyroiditis chronic | 1 0.01 97.48 Tinea pedis | 1 0.01 97.49 Tinnitus | 1 0.01 97.50 Tobacco user | 1 0.01 97.51 Tonsillitis | 1 0.01 97.52 Tooth abscess | 1 0.01 97.53 Tooth impacted | 1 0.01 97.54 Torticollis | 4 0.04 97.58 Toxicity to various agents | 2 0.02 97.60 Tracheobronchitis | 2 0.02 97.62 Transient ischaemic attack | 1 0.01 97.63 Transitional cell carcinoma | 20 0.20 97.83 Transplant rejection | 4 0.04 97.87 Trigeminal neuralgia | 4 0.04 97.91 Tuberculosis | 6 0.06 97.97 Tuberous sclerosis | 3 0.03 98.00 Type 1 diabetes mellitus | 7 0.07 98.07 Type 2 diabetes mellitus | 69 0.69 98.76 Type IIa hyperlipidaemia | 1 0.01 98.77 Tyrosinaemia | 3 0.03 98.80 Ulcer | 10 0.10 98.90 Ulcer haemorrhage | 1 0.01 98.91 Unevaluable event | 2 0.02 98.93 Upper respiratory tract infection | 3 0.03 98.96 Urinary incontinence | 4 0.04 99.00 Urinary tract infection | 14 0.14 99.14 Urine analysis abnormal | 1 0.01 99.15 Urticaria | 2 0.02 99.17 Urticaria chronic | 1 0.01 99.18 Vaginal disorder | 1 0.01 99.19 Varices oesophageal | 1 0.01 99.20 Vasculitis | 1 0.01 99.21 Venogram | 1 0.01 99.22 Venous insufficiency | 1 0.01 99.23 Ventricular fibrillation | 3 0.03 99.26 Ventricular tachycardia | 5 0.05 99.31 Vertigo | 3 0.03 99.34 Viral infection | 1 0.01 99.35 Vitamin B12 decreased | 1 0.01 99.36 Vitamin B12 deficiency | 2 0.02 99.38 Vitamin D decreased | 1 0.01 99.39 Vitamin D deficiency | 2 0.02 99.41 Vitamin K deficiency | 2 0.02 99.43 Vitamin supplementation | 23 0.23 99.66 Vomiting | 9 0.09 99.75 Vulvovaginal dryness | 3 0.03 99.78 Vulvovaginal pain | 2 0.02 99.80 Waldenstrom's macroglobulinaemia | 3 0.03 99.83 Weight abnormal | 1 0.01 99.84 Weight control | 3 0.03 99.87 Weight decreased | 7 0.07 99.94 Wheezing | 3 0.03 99.97 Withdrawal syndrome | 1 0.01 99.98 Wound infection bacterial | 1 0.01 99.99 pH urine increased | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017